[11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease

The link between amyloid and tau proteins with Alzheimer’s disease progression remains unclear. Here, the authors propose HDACs I downregulation as an element linking the deleterious effects of brain proteinopathies with disease progression.

Bibliographic Details
Main Authors: Tharick A. Pascoal, Mira Chamoun, Elad Lax, Hsiao-Ying Wey, Monica Shin, Kok Pin Ng, Min Su Kang, Sulantha Mathotaarachchi, Andrea L. Benedet, Joseph Therriault, Firoza Z. Lussier, Frederick A. Schroeder, Jonathan M. DuBois, Baileigh G. Hightower, Tonya M. Gilbert, Nicole R. Zürcher, Changning Wang, Robert Hopewell, Mallar Chakravarty, Melissa Savard, Emilie Thomas, Sara Mohaddes, Sarah Farzin, Alyssa Salaciak, Stephanie Tullo, A. Claudio Cuello, Jean-Paul Soucy, Gassan Massarweh, Heungsun Hwang, Eliane Kobayashi, Bradley T. Hyman, Bradford C. Dickerson, Marie-Christine Guiot, Moshe Szyf, Serge Gauthier, Jacob M. Hooker, Pedro Rosa-Neto
Format: Article
Language:English
Published: Nature Portfolio 2022-07-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-022-30653-5
_version_ 1818190146544074752
author Tharick A. Pascoal
Mira Chamoun
Elad Lax
Hsiao-Ying Wey
Monica Shin
Kok Pin Ng
Min Su Kang
Sulantha Mathotaarachchi
Andrea L. Benedet
Joseph Therriault
Firoza Z. Lussier
Frederick A. Schroeder
Jonathan M. DuBois
Baileigh G. Hightower
Tonya M. Gilbert
Nicole R. Zürcher
Changning Wang
Robert Hopewell
Mallar Chakravarty
Melissa Savard
Emilie Thomas
Sara Mohaddes
Sarah Farzin
Alyssa Salaciak
Stephanie Tullo
A. Claudio Cuello
Jean-Paul Soucy
Gassan Massarweh
Heungsun Hwang
Eliane Kobayashi
Bradley T. Hyman
Bradford C. Dickerson
Marie-Christine Guiot
Moshe Szyf
Serge Gauthier
Jacob M. Hooker
Pedro Rosa-Neto
author_facet Tharick A. Pascoal
Mira Chamoun
Elad Lax
Hsiao-Ying Wey
Monica Shin
Kok Pin Ng
Min Su Kang
Sulantha Mathotaarachchi
Andrea L. Benedet
Joseph Therriault
Firoza Z. Lussier
Frederick A. Schroeder
Jonathan M. DuBois
Baileigh G. Hightower
Tonya M. Gilbert
Nicole R. Zürcher
Changning Wang
Robert Hopewell
Mallar Chakravarty
Melissa Savard
Emilie Thomas
Sara Mohaddes
Sarah Farzin
Alyssa Salaciak
Stephanie Tullo
A. Claudio Cuello
Jean-Paul Soucy
Gassan Massarweh
Heungsun Hwang
Eliane Kobayashi
Bradley T. Hyman
Bradford C. Dickerson
Marie-Christine Guiot
Moshe Szyf
Serge Gauthier
Jacob M. Hooker
Pedro Rosa-Neto
author_sort Tharick A. Pascoal
collection DOAJ
description The link between amyloid and tau proteins with Alzheimer’s disease progression remains unclear. Here, the authors propose HDACs I downregulation as an element linking the deleterious effects of brain proteinopathies with disease progression.
first_indexed 2024-12-11T23:54:05Z
format Article
id doaj.art-fa6fec43d93b4296b1333a2f0ecd7e12
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-11T23:54:05Z
publishDate 2022-07-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-fa6fec43d93b4296b1333a2f0ecd7e122022-12-22T00:45:24ZengNature PortfolioNature Communications2041-17232022-07-0113111110.1038/s41467-022-30653-5[11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s diseaseTharick A. Pascoal0Mira Chamoun1Elad Lax2Hsiao-Ying Wey3Monica Shin4Kok Pin Ng5Min Su Kang6Sulantha Mathotaarachchi7Andrea L. Benedet8Joseph Therriault9Firoza Z. Lussier10Frederick A. Schroeder11Jonathan M. DuBois12Baileigh G. Hightower13Tonya M. Gilbert14Nicole R. Zürcher15Changning Wang16Robert Hopewell17Mallar Chakravarty18Melissa Savard19Emilie Thomas20Sara Mohaddes21Sarah Farzin22Alyssa Salaciak23Stephanie Tullo24A. Claudio Cuello25Jean-Paul Soucy26Gassan Massarweh27Heungsun Hwang28Eliane Kobayashi29Bradley T. Hyman30Bradford C. Dickerson31Marie-Christine Guiot32Moshe Szyf33Serge Gauthier34Jacob M. Hooker35Pedro Rosa-Neto36Translational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill UniversityTranslational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill UniversityDepartment of Molecular Biology, Ariel UniversityDepartment of Pharmacology and Therapeutics, McGill UniversityTranslational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill UniversityTranslational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill UniversityTranslational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill UniversityTranslational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill UniversityTranslational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill UniversityTranslational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill UniversityTranslational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill UniversityNeurology Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical SchoolNeurology Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical SchoolNeurology Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical SchoolNeurology Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical SchoolNeurology Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical SchoolNeurology Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical SchoolMontreal Neurological Institute, McGill UniversityDepartments of Biological and Biomedical Engineering and Psychiatry, Douglas Mental Health University Institute, Brain Imaging CentreTranslational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill UniversityTranslational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill UniversityTranslational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill UniversityDepartments of Biological and Biomedical Engineering and Psychiatry, Douglas Mental Health University Institute, Brain Imaging CentreDepartments of Biological and Biomedical Engineering and Psychiatry, Douglas Mental Health University Institute, Brain Imaging CentreDepartments of Biological and Biomedical Engineering and Psychiatry, Douglas Mental Health University Institute, Brain Imaging CentreDepartment of Pharmacology and Therapeutics, McGill UniversityMontreal Neurological Institute, McGill UniversityMontreal Neurological Institute, McGill UniversityDepartment of Psychology, McGill UniversityMontreal Neurological Institute, McGill UniversityDepartment of Neurology, Massachusetts General Hospital, Harvard Medical SchoolNeurology Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical SchoolMontreal Neurological Institute, McGill UniversityDepartment of Pharmacology and Therapeutics, McGill UniversityTranslational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill UniversityNeurology Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical SchoolTranslational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill UniversityThe link between amyloid and tau proteins with Alzheimer’s disease progression remains unclear. Here, the authors propose HDACs I downregulation as an element linking the deleterious effects of brain proteinopathies with disease progression.https://doi.org/10.1038/s41467-022-30653-5
spellingShingle Tharick A. Pascoal
Mira Chamoun
Elad Lax
Hsiao-Ying Wey
Monica Shin
Kok Pin Ng
Min Su Kang
Sulantha Mathotaarachchi
Andrea L. Benedet
Joseph Therriault
Firoza Z. Lussier
Frederick A. Schroeder
Jonathan M. DuBois
Baileigh G. Hightower
Tonya M. Gilbert
Nicole R. Zürcher
Changning Wang
Robert Hopewell
Mallar Chakravarty
Melissa Savard
Emilie Thomas
Sara Mohaddes
Sarah Farzin
Alyssa Salaciak
Stephanie Tullo
A. Claudio Cuello
Jean-Paul Soucy
Gassan Massarweh
Heungsun Hwang
Eliane Kobayashi
Bradley T. Hyman
Bradford C. Dickerson
Marie-Christine Guiot
Moshe Szyf
Serge Gauthier
Jacob M. Hooker
Pedro Rosa-Neto
[11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
Nature Communications
title [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
title_full [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
title_fullStr [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
title_full_unstemmed [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
title_short [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
title_sort 11c martinostat pet analysis reveals reduced hdac i availability in alzheimer s disease
url https://doi.org/10.1038/s41467-022-30653-5
work_keys_str_mv AT tharickapascoal 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT mirachamoun 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT eladlax 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT hsiaoyingwey 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT monicashin 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT kokpinng 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT minsukang 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT sulanthamathotaarachchi 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT andrealbenedet 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT josephtherriault 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT firozazlussier 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT frederickaschroeder 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT jonathanmdubois 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT baileighghightower 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT tonyamgilbert 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT nicolerzurcher 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT changningwang 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT roberthopewell 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT mallarchakravarty 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT melissasavard 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT emiliethomas 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT saramohaddes 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT sarahfarzin 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT alyssasalaciak 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT stephanietullo 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT aclaudiocuello 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT jeanpaulsoucy 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT gassanmassarweh 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT heungsunhwang 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT elianekobayashi 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT bradleythyman 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT bradfordcdickerson 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT mariechristineguiot 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT mosheszyf 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT sergegauthier 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT jacobmhooker 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease
AT pedrorosaneto 11cmartinostatpetanalysisrevealsreducedhdaciavailabilityinalzheimersdisease